Efficacy and Safety of Iptacopan in Patients With IgA Nephropathy (IgAN): Final 24-month Results From the Phase III APPLAUSE-IgAN Study
Back
29 Mar 2026
2:50 p.m.
3:02 p.m.
Vlado
Perkovic
Speaker
Australia